Selskabets formål er at drive handel med farmaceutiske produkter, hospitalsprodukter og diagnostik samt udvikle, producere og markedsføre teknologi og know-how i forbindelse hermed. Selskabet kan derudover yde tjenesteydelser og assistance, herunder af administrativ, driftmæssig, finansiel, forretningsmæssig, videnskabelig eller industriel karakter, i tilknytning til selskabets formål til tredjemænd, aktionærer, datterselskaber eller tilknyttede selkaber.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 473 mio. | 25 mio. | 169.2 mio. | 98 mio. | 55 | |
CVR: 34462828
Secondary names: Allergan Aesthetics A/S
Compared to 290 companies in Engroshandel med læge- og hospitalsartikler
Comparison is based on industry median values
Companies in the same industry and area
CVR 44476533
CVR 33860463
CVR 35234748
CVR 39762560
CVR 39807114
ABBVIE A/S demonstrates a positive financial trajectory, with significant revenue growth from 288.1 million DKK in 2023 to 472.9 million DKK in 2025, alongside an increase in profit from 13.7 million DKK to 25.0 million DKK during the same period. The company's equity has also improved, rising from 61.9 million DKK in 2023 to 98.0 million DKK in 2025, indicating a strengthening balance sheet. However, the equity position saw a notable decline in 2022, suggesting previous volatility. Overall, ABBVIE A/S appears to be well-positioned within the medical supply industry, benefiting from growing revenues and profits, although ongoing monitoring of its equity and profit margins is advisable.
AI-generated summary
companydata.dk